Submission of Certificate under Regulation 74(5) of Securities and exchange board of India ( Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shelter Pharma Ltd has submitted a compliance certificate confirming that Regulation 74(5) of SEBI regulations does not apply to the company. The certificate from Bigshare Services Private Limited, the company's Registrar and Share Transfer Agent, confirms that 100% of the company's shares are already held in dematerialized (demat) form. No requests were received from shareholders for rematerialization or dematerialization during the quarter ending 31st March 2026. This is a routine regulatory filing submitted to BSE within the stipulated timeframe.
This is a standard compliance filing with no direct impact on the stock price or shareholder value. It simply confirms the company's continued compliance with SEBI's dematerialization requirements.